Management Team
DDIC is headed by Dr. Raimar
Loebenberg. With over 20 years of
experience, he is a recognized expert
in the field and has affiliations to
organizations such as:
- American Association of
Pharmaceutical Scientists (AAPS)
- United States Pharmacopoeia (USP)
- Health Canada
The team members have expertise in
Formulation development and
Characterization of
- Poorly Soluble Drugs
- Novel dosage forms
- Non-conventional delivery routes
- Specialized carriers such as
Nanoparticles
To know more about the management
team please visit - www.ddic.ca
Contact Us
DDIC welcomes R&D partnerships for
Pharmaceutical Product development,
quality control and regulatory affairs.
To know more about services that
DDIC can offer please contact:
Drug Development and
Innovation Centre
Dr. Raimar Loebenberg
A Premier Centre for
Director, DDIC Pharmaceutical Research and
Associate Professor Innovation
Faculty of Pharmacy and
Pharmaceutical Sciences
1123A Dentistry/Pharmacy Centre
University of Alberta
Edmonton, Alberta - T6G 2N8
Phone: (780) 492 1255
Email: raimar@ualberta.ca
info@ddic.ca Biopharmaceutics
website: www.ddic.ca
&
Drug Delivery
Program
 Formulation Development
DDIC is a cGMP compliant facility for
development of conventional and novel
dosage forms. Our team of experts can
provide solutions for your product
development needs for:
ü
Prototype Development
ü
Proof of Concept Studies
ü
Clinical Trial Material Development
üDosage Form Development
Novel
DDIC is equipped with state-of-art
equipments for dosage forms such as:
Oral: Tablets, Capsules, Powders
ú Global linkages
Topical:
ú Ointments, Creams, Lotions,
Emulsions, Suppositories and
Microemulsions
Sterile Dosage Forms
ú
Track record of success
Our research partners include leading
global and Canadian organizations. Dr.
Loebenberg is a recognized expert in
Drug Delivery and holds several patents.
Analytical Development Regulatory Affairs
DDIC has proven expertise in Quality control DDIC can provide solutions for your
and performance testing of dosage forms. regulatory requirements such as:
Areas of expertise include:
ü
Site License Applications
Dissolution Method Development
ü ü License Applications
Product
Disintegration Testing
ü ü
Quality and Compliance
Analytical Method Development
ü ü
On-site and off-site training in
Stability studies
ü GMP, GLP
Accelerated compatibility studies
ü
using Thermal/ Bioactivity Monitor Proven expertise
Novel dosage form characterization
ü
using Franz Cells and Flow Through ?A cGMP/GLP compliant facility.
Cells
?
Trained Health Canada scientists
and inspectors in issues related to
Quality and Compliance.
?
Linkages with global organizations such as ?
Team members with work
experience in major
United States Pharmacopoeia and
American Association of Pharmaceutical pharmaceutical companies.
Scientists (AAPS).
?Enables seamless transition of molecules
from lab to clinic and beyond through
linkages with NACTRC, ARC ToxTest, Cross
Cancer Institute.
visit us at www.ddic.ca